Did Dismissals of Safe Outpatient Drugs Cause Needless COVID Deaths? Dissenting Doctors Say Yes

Did Dismissals of Safe Outpatient Drugs Cause Needless COVID Deaths? Dissenting Doctors Say Yes
A health worker shows a box containing a bottle of ivermectin in Cali, Colombia, on July 21, 2020. Luis Robayo/AFP via Getty Images
Clayton Fox
RealClearInvestigations
Updated:
0:00

For the first nine months of the COVID-19 pandemic, there were no officially approved outpatient treatments for combating the disease. From March 2020, when the virus first emerged in the United States, until that November, when the Food and Drug Administration authorized emergency use of monoclonal antibodies, health authorities advised that the infected do little but quarantine themselves, drink plenty of fluids and rest unless hospitalization was necessary.

During those chaotic final months of Donald Trump’s presidency, the medical establishment expressed extreme caution regarding outpatient treatments for the virus, and these warnings were amplified by major media hostile to the president, for example when he touted the anti-malaria medicine hydroxychloroquine.

Clayton Fox was a 2020 Tablet Magazine Fellow. He has been published at Tablet, RealClearInvestigations, Los Angeles Magazine, JancisRobinson.com, and the Brownstone Institute.
Related Topics